The first study to suggest a role of GSTP1 polymorphisms in pancreatic pathogenesis concluded that genetic polymorphisms of GSTP1 may be among the mechanisms that modify the risk of pancreatic cancer in older individuals and affect the survival of patients who receive 5-fluorouracil-based treatment [146]. This evidence concerns the gene GSTP1 and pancreatic neoplasm.